The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma
about
Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical studyBnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signalingQuantitative ultrasound characterization of tumor cell death: ultrasound-stimulated microbubbles for radiation enhancement.Locally advanced noninflammatory breast cancer.Rapid Stereomicroscopic Imaging of HER2 Overexpression in Ex Vivo Breast Tissue Using Topically Applied Silica-Based Gold Nanoshells.Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.Significance of histopathological evaluation in primary therapy for breast cancer--recent trends in primary modality with pathological complete response (pCR) as endpoint.Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.Cytological Study of Breast Carcinoma Before and After Oncotherapy with Special Reference to Morphometry and Proliferative Activity.89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast TumorsVariation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature.Histopathologic changes following neoadjuvant chemotherapy in various malignancies.The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma.Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer.Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects.Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice.Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy.A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.Impact of Her-2 Overexpression on Survival of Patients with Metastatic Breast CancerPrognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.Breast cancer patients should not live without a HER-2/neu tissue result--but how safe can they live with it?Invasive Ductal Carcinoma Breast: How Neoadjuvant Chemotherapy Affects the Status of Estrogen Receptor, Progesterone Receptor and HER2/Neu-A Tertiary Care Centre Study.p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer.c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy.HER-2/neu Assessment in Primary Chemotherapy Treated Breast Carcinoma: No Evidence of Gene Profile Changing
P2860
Q24803269-6A946B69-4AB4-4502-8E46-A50ABEAB3357Q28580570-6D987F13-58C8-4897-8E60-BFF6D35F8E83Q30434411-028B94EB-5E60-44A0-9B68-E6AD97C3F904Q33547204-4DE6584A-EBA2-4F36-9253-2C92400DA18EQ34469087-246449A1-F733-4EEA-B02F-855ADD80B5D6Q35586669-04DA79B0-7F89-4F00-BD5B-61127D033571Q35954237-C42837A7-A267-4584-A4C1-24FEBD6D7F88Q36136174-E57015E1-AB7D-47CB-8EF6-3C6CB74CA4E7Q36408773-E8A22F1D-7B8E-4BAC-80E6-F211201FF88CQ37148669-7BD69CAD-A129-405E-8F8B-D0FA2A0F2085Q37812122-7F67BCDF-02B7-4C77-B431-A9DF779C6C8EQ38115304-C554B37A-EAF0-4B3F-BE88-A19C9E554F68Q38427892-BA0D437A-8E2D-49BE-A572-FED52CF02A42Q38505400-B2E7A4A4-E3A8-40F2-8946-304439BA5861Q40923622-33D069DE-DD6D-47CC-836D-544FEDFD4DB7Q41060619-6DCD04BB-4951-49AF-913B-ABA395F71B6DQ41547969-B74B60DE-C366-4846-983B-D88AF0FE0EC8Q42759889-6AFD1015-03D7-4738-A818-B5D38C910CF8Q44711355-5D234897-260A-49A7-9327-54704625B489Q46568787-578D247D-17D1-481D-BBCA-020CCF3C29E1Q47714743-7290D5B6-058F-45AD-8DBC-1BF47417EFC1Q47928690-FE3485C5-7455-4AC2-8B64-DC7828E71CE3Q47928703-39C97BE1-3359-48F5-AA65-1137F7473A86Q48002839-B8564EFF-BEA0-40A2-A617-9539C8EF6DDBQ48024917-CCA3A498-0958-4BA7-8EFE-7D0FF75BAAE9Q48334436-DF46BF61-B73D-4AEA-A884-BB024665BE8BQ54168789-59A4953A-5B92-4353-96B7-3B63B640F44EQ58813403-7B1FCEBA-BC4D-45E8-B310-D31BC7503025
P2860
The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The effects of chemotherapy on ...... on in primary breast carcinoma
@ast
The effects of chemotherapy on ...... on in primary breast carcinoma
@en
type
label
The effects of chemotherapy on ...... on in primary breast carcinoma
@ast
The effects of chemotherapy on ...... on in primary breast carcinoma
@en
prefLabel
The effects of chemotherapy on ...... on in primary breast carcinoma
@ast
The effects of chemotherapy on ...... on in primary breast carcinoma
@en
P2093
P2860
P356
P1476
The effects of chemotherapy on ...... on in primary breast carcinoma
@en
P2093
Gillett CE
Rasbridge SA
Richards MA
Seymour AM
P2860
P2888
P304
P356
10.1038/BJC.1994.303
P407
P577
1994-08-01T00:00:00Z